EQL Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is April - March.

Millions SEK. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	72.67	82.4	20.47	44.43	41.2	26.58
Cash & Short-Term Investments	72.67	82.4	20.47	44.43	41.2	26.58
Cash Growth	367.14%	302.58%	-53.93%	7.83%	55.01%	157.80%
Accounts Receivable	81.37	130.72	60.77	51.7	34.1	22.08
Other Receivables	26.03	1.4	5.21	0.96	0.71	4.22
Receivables	107.4	132.12	65.98	52.66	34.81	26.3
Inventory	196.66	179.03	105.63	65.37	41.67	42.36
Prepaid Expenses	-	6.25	4.75	4.2	2.24	0.32
Other Current Assets	-	0.45	0.94	0.57	3.53	2.27
Total Current Assets	376.73	400.25	197.77	167.23	123.45	97.82
Property, Plant & Equipment	5.42	6.33	2.67	3.15	4.19	5.01
Long-Term Investments	0	0	0	0	0	0
Other Intangible Assets	431.39	364.67	149.08	102.54	98.41	93.68
Long-Term Deferred Tax Assets	-	-	-	-	-	0.3
Long-Term Deferred Charges	-	37.58	24.24	12.78	11.83	6.7
Other Long-Term Assets	-0	-0	-	-	-	-
Total Assets	813.54	808.82	373.76	285.7	237.89	203.51
Accounts Payable	45.33	90.94	49.83	29.61	15.98	19.03
Accrued Expenses	-	10.29	6.65	17.87	16.28	4.48
Short-Term Debt	95.58	107.41	102.22	63.7	59.32	64.41
Current Portion of Long-Term Debt	-	4.11	-	-	5.4	5.4
Current Portion of Leases	-	2.75	1.4	1.21	-	-
Current Income Taxes Payable	-	-	-	0.14	-	-
Other Current Liabilities	33.46	1.53	1.43	4.66	1.64	1.48
Total Current Liabilities	174.37	221.02	162.05	117.19	98.76	94.93
Long-Term Debt	341.5	338.39	15.45	-	7.2	12.6
Long-Term Leases	-	3.05	1.02	1.71	4.18	4.76
Long-Term Deferred Tax Liabilities	27.89	25.34	17.51	12.05	4.12	-
Other Long-Term Liabilities	0	0	-	0	-	-
Total Liabilities	543.76	587.79	196.03	130.94	114.26	112.29
Common Stock	269.78	1.31	1.31	1.31	1.31	1.31
Additional Paid-In Capital	-	67.64	67.45	67.18	66.99	66.13
Retained Earnings	-	152.08	108.97	86.26	55.33	23.78
Comprehensive Income & Other	-	-	-0	-	-	-
Shareholders' Equity	269.78	221.03	177.73	154.75	123.63	91.22
Total Liabilities & Equity	813.54	808.82	373.76	285.7	237.89	203.51
Total Debt	437.08	455.71	120.09	66.62	76.1	87.17
Net Cash (Debt)	-364.41	-373.31	-99.63	-22.19	-34.9	-60.59
Net Cash Per Share	-12.17	-12.49	-3.34	-0.75	-1.20	-2.08
Filing Date Shares Outstanding	29.53	29.06	29.06	29.06	29.06	29.06
Total Common Shares Outstanding	29.53	29.06	29.06	29.06	29.06	29.06
Working Capital	202.36	179.23	35.72	50.04	24.7	2.89
Book Value Per Share	9.14	7.61	6.12	5.32	4.25	3.14
Tangible Book Value	-161.61	-143.63	28.65	52.21	25.21	-2.46
Tangible Book Value Per Share	-5.47	-4.94	0.99	1.80	0.87	-0.08
Machinery	-	4.47	3.17	0.99	2.14	1.43

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.